605 related articles for article (PubMed ID: 7909185)
1. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
2. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
3. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
4. p53 expression in placentas with hydropic change and hydatidiform moles.
Cheville JC; Robinson RA; Benda JA
Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
[TBL] [Abstract][Full Text] [Related]
5. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
6. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
7. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
8. [Detection of p53 gene mutations in human gestational trophoblastic neoplasia by polymerase chain reaction-single strand conformational polymorphism techniques].
Wu Y; Zhang Q; Tang H
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):338-40. PubMed ID: 9868092
[TBL] [Abstract][Full Text] [Related]
9. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
10. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas.
Cheung AN; Srivastava G; Chung LP; Ngan HY; Man TK; Liu YT; Chen WZ; Collins RJ; Wong LC; Ma HK
J Reprod Med; 1994 Mar; 39(3):223-7. PubMed ID: 8035377
[TBL] [Abstract][Full Text] [Related]
11. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
12. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
Shih IM; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
Wong SY; Ngan HY; Chan CC; Cheung AN
Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
[TBL] [Abstract][Full Text] [Related]
15. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor].
Zhou J; Chen SL; Xing FQ; Pang ZJ; Li B; Zhou WQ; Fu X; Ding YQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):171-3. PubMed ID: 15698997
[TBL] [Abstract][Full Text] [Related]
16. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases.
Uzunlar AK; Yilmaz F; Bayhan G; Akkuş Z
Eur J Gynaecol Oncol; 2002; 23(1):79-83. PubMed ID: 11876401
[TBL] [Abstract][Full Text] [Related]
17. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
19. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
20. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
Lei ZM; Rao CV; Ackerman DM; Day TG
J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]